Faessel HM
No ORCID on file
· 1 paper in corpus
· active 2015
Top journals
Frequent coauthors
- MacLean DB 1
- Saad F 1
- Shi H 1
2015
ContextTAK-385 is a highly selective, oral, nonpeptide GnRH antagonist being investigated as a possible prostate cancer treatment.ObjectiveThe objectives were to evaluate safety, tolerability, pharmacokinetics, and pharmacodynamics of TAK-3…